This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Nanjing Ruijie Pharma Co., Ltd., Nanjing Ruijie Pharma Co., Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Innovations by Xiaoxin Qi in Thyroid Hormone Research
Introduction
Xiaoxin Qi is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that act as thyroid hormone receptor agonists. His work is crucial for addressing various metabolic disorders.
Latest Patents
Xiaoxin Qi holds a patent for "Compounds and their uses as thyroid hormone receptor agonists." This patent includes a compound of formula (I) or (Ia), along with its tautomers or pharmaceutically acceptable salts. Additionally, compounds of formulas (II) to (V) are also covered under this patent. These compounds and the pharmaceutical compositions containing them are useful for treating diseases such as obesity, hyperlipidemia, hypercholesterolemia, and diabetes. They may also be beneficial for other conditions like NASH, atherosclerosis, cardiovascular diseases, hypothyroidism, and thyroid cancer.
Career Highlights
Xiaoxin Qi is associated with Nanjing Ruijie Pharma Co., Ltd., where he continues to innovate in the pharmaceutical sector. His research focuses on developing effective treatments for metabolic and endocrine disorders.
Collaborations
Xiaoxin Qi collaborates with Junbo Zhang, contributing to advancements in their field through shared expertise and research efforts.
Conclusion
Xiaoxin Qi's innovative work in thyroid hormone receptor agonists represents a significant advancement in the treatment of various metabolic disorders. His contributions are vital for the ongoing development of effective pharmaceutical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile